Palisade Bio Inc Share Price Today: Live Updates & Key Insights

Palisade Bio Inc share price today is $1.88, up -5.03%. The stock opened at $1.98 against the previous close of $1.99, with an intraday high of $2.015 and low of $1.85.

Palisade Bio Inc Share Price Chart

Palisade Bio Inc

us-stock
To Invest in {{usstockname}}
us-stock

Palisade Bio Inc Share Price Performance

$1.88 -0.0503(-5.03%) PALI at 23 Mar 2026 02:39 PM Biotechnology
Lowest Today 1.85
Highest Today 2.015
Today’s Open 1.98
Prev. Close 1.99
52 Week High 2.64
52 Week Low 0.53
Day’s Range: Low 1.85 High 2.015
52-Week Range: Low 0.53 High 2.64
1 day return -
1 Week return -5.0
1 month return +17.28
3 month return -9.09
6 month return +203.46
1 year return +179.41
3 year return -92.32
5 year return -99.97
10 year return -

Palisade Bio Inc Institutional Holdings

COMMODORE CAPITAL LP 7.67

Octagon Capital Advisors LP 6.41

RA Capital Management, LLC 4.78

Boxer Capital Management, LLC 3.22

Adage Capital Partners Gp LLC 3.02

B Group, Inc 3.02

Squadron Capital Management LLC 3.02

StemPoint Capital LP 2.81

Franklin Biotechnology Discv A(acc)USD 2.25

Renaissance Technologies Corp 1.60

Vivo Capital, LLC 1.54

Franklin Biotechnology Discovery A 1.42

Vanguard Group Inc 1.42

ADAR1 Capital Management LLC 1.34

Artia Global Partners LP 1.34

Biotech Growth Ord 1.25

Orbimed Advisors, LLC 1.25

Citadel Advisors Llc 1.14

Geode Capital Management, LLC 1.05

Vanguard Institutional Extnd Mkt Idx Tr 0.93

HighVista Strategies LLC 0.87

Exome Asset Management LLC 0.51

Fidelity Extended Market Index 0.46

Hudson Bay Capital Management LP 0.44

Persistent Asset Partners Limited 0.28

Blackrock Extended Mkt Fund CF 0.25

Simplify Propel Opportunities ETF 0.23

Extended Equity Market Fund K 0.22

Fidelity Total Market Index 0.18

Fidelity Series Total Market Index 0.15

Spartan Extended Market Index Pool F 0.12

NT Ext Equity Mkt Idx Fd - L 0.10

NT Ext Equity Mkt Idx Fd - NL 0.08

Spartan Total Market Index Pool G 0.07

LUX IM Global Medtech HX 0.07

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.07

Fidelity Nasdaq Composite Index 0.06

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.04

Vanguard U.S. Eq Idx £ Acc 0.04

Virtus Systematic U.S. Small Cap 0.03

Palisade Bio Inc Market Status

Strong Buy: 2

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Palisade Bio Inc Fundamentals

Market Cap 296.91 M

PB Ratio 88.3134

PE Ratio 0.0

Enterprise Value 278.47 M

Total Assets 134.34 M

Volume 2956156

Palisade Bio Inc Company Financials

Annual Revenue FY23:250000 0.3M, FY22:0 0.0M, FY21:0 0.0M, FY20:13520 0.0M, FY19:15394 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:13520 0.0M, FY19:15394 0.0M

Annual Net worth FY23:-13049000 -13.0M, FY22:-12799000 -12.8M, FY21:-27271000 -27.3M, FY20:-10570000 -10.6M, FY19:-8351651 -8.4M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-1000 -0.0M, Q1/2025:-1000 -0.0M, Q3/2024:null 0.0M, Q2/2024:-1000 -0.0M

Quarterly Net worth Q3/2025:-2868000 -2.9M, Q2/2025:-2784000 -2.8M, Q1/2025:-2230000 -2.2M, Q3/2024:-3487000 -3.5M, Q2/2024:-4080000 -4.1M

About Palisade Bio Inc & investment objective

Company Information Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for the treatment of fibrostenotic crohn's disease. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company is headquartered in Carlsbad, California.

Organisation Biotechnology

Employees 8

Industry Biotechnology

CEO Mr. J. D. Finley

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Palisade Bio Inc FAQs

What is the share price of Palisade Bio Inc today?

The current share price of Palisade Bio Inc is $1.88.

Can I buy Palisade Bio Inc shares in India?

Yes, Indian investors can buy Palisade Bio Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Palisade Bio Inc shares in India?

You can easily invest in Palisade Bio Inc shares from India by:

Can I buy fractional shares of Palisade Bio Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Palisade Bio Inc?

Palisade Bio Inc has a market cap of $296.91 M.

In which sector does Palisade Bio Inc belong?

Palisade Bio Inc operates in the Biotechnology sector.

What documents are required to invest in Palisade Bio Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Palisade Bio Inc?

The PE ratio of Palisade Bio Inc is N/A and the PB ratio is 88.31.